Share Structure - Updated September 2, 2024:
Transfer
Share Structure - Updated September 2, 2024:
Transfer Agent Verified
No change - no dilution
Authorized Shares: 12,000,000,000
Outstanding Shares: 3,142,243,272
Restricted: 383,572,035
Unrestricted: 2,758,671,237
Note 1: It is only the Unrestricted Outstanding Shares count that is relevant to current trading.
Note 2: Relatively low Unrestricted Outstanding Shares count - only 2.7B - for a stock in the .0001 > .1 range.
American EcoFuels Inc (AEFI) Stock Research Links
"Per Ardua Ad Astra" - "Through Adversity To The Stars"
A very apposite motto for those who trade successfully in the OTC market..
All posts are my opinion - trade at your own risk.
Scroll down for more posts ▼
Top 10 Most Recent News Articles
Exploring a New Front in Cancer Treatment Johnson & Johnson (NYSE: JNJ) just dropped a bombshell at the Society for Immunotherapy of Cancer (SITC) 2026 Annual Meeting, unveiling data that could reshape prostate cancer care. Their pioneering combo of pasritamig and JNJ-9401, a dual-antigen-targeted therapy, has the scientific community buzzing. Yeah, it's just Phase 1 baby...
Continue Reading
Quantum Space Bags a Chunk of NASA's Lunar Ambitions Alright, folks, buckle up because we're about to dive into the cosmos. Quantum Space just nabbed a sweet deal—a $185 million whopper of a contract from NASA's Moon Base Transportation program. This isn't chump change; it's a 25% slice for Quantum from the lot Arrow Science and Technology is heading. We're talking...
Continue Reading
The Clock is Ticking for Webull Investors If anyone's got a Webull stake, listen up! You’ve got a deadline that's staring you in the face: December 7, 2026. This is when you need to throw your hat in the ring to be a lead plaintiff in the Webull Corporation class action. We're talking securities fraud, folks, with allegations flying that would make your head spin....
Continue Reading
MWC26 Doha Launches with a Connectivity Mission Forget corporate boardrooms; the real action this week is unfolding in Doha's bustling exhibition halls. Kicked off with the fanfare you'd expect from such a key event, MWC26 Doha has drawn a crowd that's got both tech geeks and policy wonks nodding with interest. This ain’t your average trade show: it’s the melting pot...
Continue Reading
A Looming Legal Storm for D-Wave Investors Call it another day, another legal tangle in the investing world. This time, it's D-Wave Quantum Inc. (NASDAQ: QBTS) on the receiving end of a securities fraud class action lawsuit. Yeah, those fancy quantum computers they're pushing didn't predict this one coming. The legal arena is getting ready for a bout, and if you've got...
Continue Reading
Data Breach Fallout: Amplifon Under Fire When a big player like Amplifon gets hit with a data breach, it's like a wake-up call across the board. This one’s no small spill—over 1.3 million folks left wondering whether their personal information is fluttering around cyberspace for all who dare to peek. If you’ve missed the memo, Edelson Lechtzin LLP, the savvy cats in...
Continue Reading
Boosting IoT with Satellite Connectivity Here's a good one for folks watching the edge of wireless innovation. Fibocom's LTE Cat.1 bis modules, the LE270-EU and LE271-GL, just stretched their legs in New Zealand, connecting seamlessly with SpaceX's Direct to Cell (DTC) satellite system. No fancy hardware swaps, just standard firmware strutting its stuff across satellite...
Continue Reading
Exploring New Horizons in Display Technology There's something brewing in Wuhan: a conference that’s shaping up like a tech enthusiast’s dream. This year, it's all about the symbiosis of cutting-edge tech and dazzling visuals as TCL CSOT gears up to unveil advancements at the Global Display Tech-Ecosystem Conference (DTC) 2026. If you're wondering whether this event...
Continue Reading
Securities Fraud Allegations Hit AST SpaceMobile Days like this remind me why we keep our eyes peeled in the stock game—AST SpaceMobile (NASDAQ: ASTS) is tangled in a web of legal drama, and it's something you can't brush off with a shrug. Class action lawsuits for securities fraud? That's like finding out the foundation's shaky beneath a skyscraper. If you've got skin...
Continue Reading
Enhanced Patient Satisfaction with Aesthetic Treatments Dive into the latest studies from Allergan Aesthetics—AbbVie's heavyweight in the beauty battleground. If you've got an ounce of optimism left in this market, their recent findings might just lift your spirits. Phase 4 studies, namely HARMONY IN DIVERSITY and HALO, are showing highly positive results among patients...
Continue Reading
Top 5 Most Recently Viewed Articles
Vantage as a Platinum Partner of AIESEC FHN Vantage is proud to highlight its inspirational collaboration with AIESEC FHN, a partnership dedicated to empowering youth leadership development. This initiative significantly impacted the career trajectories of numerous young individuals seeking growth within a competitive landscape. The Mission of AIESEC AIESEC stands as a...
Continue Reading
Nicox Excels in Fourth Quarter Financial Performance Nicox SA, an international ophthalmology company known for its innovative solutions, has unveiled its financial performance for the fourth quarter of 2024. The results reflect the company's resilience and strategic direction as it continues to navigate the complexities of the ophthalmic landscape. Key Financial...
Continue Reading
International Paper's New Acquisition Strategy International Paper, a prominent player in the packaging industry based in the United States, has recently achieved a significant milestone by receiving the European Union's approval for its acquisition of DS Smith, a UK competitor. This strategic move, valued at approximately $7.2 billion, comes as part of International...
Continue Reading
Markets Today: Futures, Debate Fallout, and Sector Shifts Stock futures are drifting lower as traders weigh two things at once: upcoming US inflation data and a combative debate between presidential candidates Donald Trump and Kamala Harris. The exchange was lively—lots of heat, fewer specifics—leaving investors still hunting for clear economic plans. Meanwhile,...
Continue Reading
Trogenix: A Revolutionary Approach to Cancer Treatment In the rapidly evolving domain of cancer therapies, Trogenix Ltd has emerged with a groundbreaking platform designed to transform cancer treatment, especially for aggressive forms like glioblastoma. Originating from the innovative research of the University of Edinburgh, Trogenix is on a mission to elevate the...
Continue Reading